Variability in the clinical expression of Parkinson's disease

Journal of the Neurological Sciences

Volumn 266, Issue 1-2, 2008, Pages 197-203

  Wolters, Erik Ch ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinicopathological correlations; Early (pre motor) diagnosis; Non motor symptoms; Parkinson's disease

Indexed keywords

ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; COGNITIVE DEFECT; EARLY DIAGNOSIS; FATIGUE; HUMAN; HYPOSMIA; MOOD DISORDER; NEUROPATHIC PAIN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DISORDER;

AUTONOMIC NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; HUMANS; MOOD DISORDERS; MUSCLE FATIGUE; OLFACTION DISORDERS; PAIN; PARKINSON DISEASE; SLEEP DISORDERS;

EID: 38749132488     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.08.016     Document Type: Article

References (61)

1. Calne D. A definition of Parkinson's disease. Parkinsonism Relat Disord 11 S1 (2000) S39-S40
2. In: Wolters E.Ch., and Scheltens P. (Eds). Mental dysfunction in Parkinson's disease (1993), Gorcum, ICG
3. Lewis S.J.G., Foltynie T., Blackwell A.D., Robbins T.W., Owen A.M., and Barker R.A. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76 (2005) 343-348
4. Uitti R.J., Baba Y., Wszolek Z.K., and Putzke D.J. Defining the Parkinson disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. Parkinsonism Relat Disord 11 (2005) 139-145
5. Braak H., and Braak E. Pathoanatomy of Parkinson's disease. J Neurol 247 S2 (2000) S3-S10
6. Braak H., Del Tredici K., Rueb U., de Vos R.A.I., Jansen Steur E.N.H., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 (2003) 197-211
7. Braak H., Ghebremedhin E., Ru{double acute}b U., Bratzke H., and Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318 (2004) 121-134
8. Doder M., Rabiner E.A., Turjanski N., Lees A.J., and Brooks D.J. Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology 60 (2003) 601-605
9. Remy P., Doder M., Lees A., Turjanski N., and Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128 (2005) 1314-1322
10. Brooks J.J. Imaging the dopamine system in Parkinson's disease. In: Wolters E.Ch., Berendse H.W., and Stam C.J. (Eds). Mental dysfunction in Parkinson's disease III (2006), VU Medical Press, Amsterdam 247-264
11. Murai T., Muller U., Werheid K., et al. In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13 (2001) 222-228
12. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L.F., Wolters E.Ch., and Berendse H.W. Idiopatic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56 (2004) 173-181
13. Berendse H.W., Booij J., Francot Ch., et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 50 (2001) 34-41
14. Booij J., Tissingh G., Winogrodzka A., and van Royen E.A. Imaging of the dopaminergic neurotransmission system using single- photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 26 (1999) 171-182
15. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
16. Morris R.G., Downes J.J., Sahakian B.J., Evenden J.L., Heald A., and Robbins T.W. Planning and spatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 757-766
17. Marek K., Innis R., van Dyck C., et al. [(123)I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology 57 (2001) 2089-2094
18. Tissingh G., Bergmans P., Booij J., et al. Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT. J Neurol 245 (1998) 14-20
19. Tissingh G., Booij J., Bergmans P., et al. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med 39 (1998) 1143-1148
20. Del Tredici K., Rub U., De Vos R.A.I., Bohl J.R.E., and Braak H. Where does Parkinson disease pathology begin in the brain?. J Neuropathol Exp Neurol 61 (2002) 413-426
21. Gonera E.G., van't Hof M., Berger H.J., van Weel C., and Horstink M.W.I.M. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 12 (1997) 871-876
22. Oppenheimer D.R. Lateral horn cells in progressive autonomic failure. J Neurol Sci 46 (1980) 393-404
23. Braak H., Ru{double acute}b U., Gai W.P., and Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110 (2003) 517-536
24. Hawkes C.H., Shephard B.C., and Daniel S.E. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62 (1997) 436-446
25. Montgomery E.B., Baker K.B., Lyons K., and Koller W. Abnormal performance on the PD test battery by asymptomatic first degree relatives. Neurology 52 (1999) 757-762
26. Giuffrida R., Vingerhoets F.J.G., Bogousslavsky J., and Ghika J. Pain in Parkinson's disease. Rev Neurol (Paris) 161 (2005) 407-418
27. Scherder E., Wolters E., Polman C., Sergeant J., and Swaab D. Pain in Parkinson's disease and multiple sclerosis: relation to the medial and lateral pain systems. Neurosci Biobehav Rev 29 (2005) 1047-1056
28. Schuurman A.G., van den Akker M., Ensinck K.T.J.L., et al. Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 58 (2002) 1501-1504
29. Pacchetti C., Manni R., Zangaglia R., et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 20 (2005) 1439-1448
30. Schenck C.H., Bundlie S.R., and Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic REM sleep disorder behavior. Neurology 46 (1996) 388-393
31. Mahieux F., Fenelon G., Flahault A., Manifacier M.J., Michelet D., and Boller F. Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 64 (1998) 178-183
32. Simard M., van Reekum R., and Cohen T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 12 (2000) 425-450
33. Stiasny-Kolster K., Doerr Y., Moller J.C., et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128 (2005) 126-137
34. Fantini M.L., Ferini-Strambi L., and Montplaisir J. Idiopathic REM sleep behavior disorder: toward a better nosologic definition. Neurology 64 (2005) 780-786
35. Cummings J.L. Dementia with Lewy bodies: molecular pathogenesis and implications for classification. J Geriatr Psychiatry Neurol 17 (2004) 112-119
36. Braak H., Ru{double acute}b U., Jansen Steur E.N.H., Del Tredici K., and de Vos R.A.I. Cognitive status correlates with neuropathologic stage in Parkinson's disease. Neurology 64 (2005) 1404-1410
37. Tissingh G., de Waard R., Bergmans P., Drukarch B., Stoof J.C., and Wolters E.Ch. Loss of olfactory discrimination in de-novo Parkinson's disease patients. Mov Disord 16 (2001) 41-46
38. Friedman J.H. Fatigue in Parkinson's disease. Int J Neuropsychopharmacol 9 S1 (2006) S14-S15
39. Chaudhuri K.R., Yates L., and Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 5 (2005) 275-283
40. Dubois B., and Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 244 (1997) 2-8
41. Larner A.J., Mathias C.J., and Rossor M.N. Autonomic failure preceding dementia with Lewy bodies. J Neurol 247 (2000) 229-231
42. Stoffers D., Berendse H.W., Deijen J.B., and Wolters E.Ch. Motor perseveration is an early sign in Parkinson's disease. Neurology 57 (2001) 2111-2113
43. Micieli G., Tosi P., Marcheselli S., and Cavallini A. Autonomic dysfunction in Parkinson's disease. Neurol Sci 24 S1 (2003) S32-S34
44. Koller W.C. Neuroprotection for Parkinson's disease. Ann Neurol 44 S1 (1998) S155-S159
45. Przuntek H., Muller T., and Riederer P. Diagnostic staging of Parkinson's disease: conceptual aspects. J Neural Transm 111 (2004) 201-216
46. Ford B. Pain in Parkinson's disease. Clin Neurosci 5 (1998) 63-72
47. Rub U., del Tredici K., Schultz C., et al. Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology. Neurobiol Aging 23 (2002) 245-254
48. Magerkurth C., Schnitzer R., and Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res 15 (2005) 76-82
49. Bonuccelli U., Lucetti C., Del Dotto P., et al. Orthostatic hypotension in de novo Parkinson disease. Arch Neurol 60 (2003) 1400-1404
50. Singleton A., Gwinn-Hardy K., Sharabi Y., et al. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 127 (2004) 768-772
51. Amino T., Orimo S., Itoh Y., Takahashi A., Uchihara T., and Mizusawa H. Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 15 (2005) 29-34
52. Waxman M.J., Durfee D., Moore M., Morantz R.A., and Koller W. Nutritional aspects and swallowing function of patients with Parkinson's disease. Nutr Clin Pract 5 (1990) 196-199
53. Soler J.M., and Le Portz B. Bladder sphincter disorders in Parkinson's disease. Ann Urol (Paris) 38 S2 (2004) S57-S61
54. Bronner G., Royter V., Korczyn A.D., and Giladi N. Sexual dysfunction in Parkinson's disease. J Sex Marital Ther 30 (2004) 95-105
55. Yu M., Roane D.M., Miner C.R., Fleming M., and Rogers J.D. Dimensions of sexual dysfunction in Parkinson's disease. Am J Geriatr Psychiatry 12 (2004) 221-226
56. Hocherman S., and Giladi N. Visuomotor control abnormalities in patients with unilateral parkinsonism. Neurology 50 (1998) 1648-1654
57. Sage J.I., and Mark M.H. Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile. Ann Neurol 37 (1995) 120-122
58. Aarsland D., and Ehrt U. The epidemiology of mental dysfunction in Parkinson's disease. In: Wolters E.Ch., Berendse H.W., and Stam C.J. (Eds). Mental dysfunction in Parkinson's disease III (2006), VU Medical Press, Amsterdam 95-106
59. Arnulf I., Konofal E., Merino-Andreu M., et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 58 (2002) 1019-1024
60. Brown R.G., Soliveri P., and Jahanshahi M. Executive processes in Parkinson's disease - random number generation and response suppression. Neuropsychologia 36 (1998) 1355-1362
61. Bosboom J.L.W., Stoffers D., and Wolters E.Ch. Cognitive function in Parkinson's disease. J Neural Transm 111 (2004) 1303-1315